Nanosonics Limited ( (AU:NAN) ) just unveiled an announcement.
Nanosonics Limited announced the release of its FY25 half-year financial results, scheduled for February 20, 2025. An investor conference call will be hosted by the company’s CEO and CFO on the same day, offering insights into the company’s performance and future directions, reinforcing its commitment to transparency and stakeholder engagement.
More about Nanosonics Limited
Nanosonics Limited is a company specializing in infection control solutions, focusing on innovative technologies to enhance safety in healthcare environments.
YTD Price Performance: 20.32%
Average Trading Volume: 1,130
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $682.3M
For detailed information about NAN stock, go to TipRanks’ Stock Analysis page.